Targeted next-generation sequencing revealed distinct clinicopathologic and molecular features of VCL-ALK RCC: A unique case from an older patient without clinical evidence of sickle cell trait
- 1 November 2019
- journal article
- research article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 215 (11) , 152651
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Jiangsu Province
- National Natural Science Foundation of China
This publication has 26 references indexed in Scilit:
- Genetic analysis and clinicopathological features of ALK‐rearranged renal cell carcinoma in a large series of resected Chinese renal cell carcinoma patients and literature reviewHistopathology, 2017
- VCL-ALK Renal Cell Carcinoma in Children With Sickle-cell TraitAmerican Journal of Surgical Pathology, 2014
- ALK-Positive Renal Cell Carcinoma in a Large Series of Consecutively Resected Korean Renal Cell Carcinoma PatientsThe Korean Journal of Pathology, 2013
- ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patientsLaboratory Investigation, 2012
- Identification of anaplastic lymphoma kinase fusions in renal cancerCancer, 2012
- Renal cell carcinoma with novel VCL–ALK fusion: new representative of ALK-associated tumor spectrumLaboratory Investigation, 2011
- ALK rearrangement in sickle cell trait‐associated renal medullary carcinomaGenes, Chromosomes and Cancer, 2010
- Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancerNature, 2007
- TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic TumorsThe American Journal of Pathology, 2000
- Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's LymphomaScience, 1994